Shigella
Shigella is a genus of bacteria that is Gram-negative, non-spore-forming, rod-shaped, and closely related to Escherichia coli and Salmonella. The causative agent of human shigellosis, Shigella causes disease in primates, but not in other mammals. It is only naturally found in humans and gorillas. During infection, it typically causes dysentery.
Classification[edit]
Shigella species are classified by three serogroups and one serotype:
- Shigella dysenteriae (group A)
- Shigella flexneri (group B)
- Shigella boydii (group C)
- Shigella sonnei (group D)
Pathogenesis[edit]
Shigella infection is typically via ingestion (fecal–oral contamination); depending on age and condition of the host, fewer than 100 bacterial cells can be enough to cause an infection. Shigella uses a type-III secretion system, which acts as a biological syringe to translocate toxic effector proteins to the target human cell.
Symptoms[edit]
Symptoms may range from mild abdominal discomfort to full-blown dysentery characterized by cramps, diarrhea, with slimy, bloody stools, fever, and vomiting. Symptoms typically appear 1–2 days after exposure, and recovery occurs in 5–7 days. In some cases, individuals may develop hemolytic uremic syndrome (HUS) leading to kidney failure.
Treatment[edit]
Shigella infection is typically self-limiting, and in most cases, antibiotic treatment is not required. However, when necessary, antibiotics can be used. Resistance to antibiotics is common, so testing to determine which antibiotics will work is often needed.
Prevention[edit]
Prevention of shigellosis is through good hand hygiene and avoidance of food and water contaminated with fecal material.
See also[edit]
Shigella[edit]
-
Shigella stool
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
